← Back to Search

Implant

MatrixRIB for Multiple Rib Fractures (MatrixRIB Trial)

N/A
Waitlist Available
Led By Michael Bottlang, PhD
Research Sponsored by Legacy Biomechanics Laboratory
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this observational study is to document the treatment of serial rib fractures with MatrixRIB implants in a registry.

Eligible Conditions
  • Multiple Rib Fractures
  • Flail Chest

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: MatrixRIBExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MatrixRIB (FDA Approval # K081623)
2008
N/A
~20

Find a Location

Who is running the clinical trial?

Legacy Biomechanics LaboratoryLead Sponsor
1 Previous Clinical Trials
33 Total Patients Enrolled
Synthes Inc.Industry Sponsor
13 Previous Clinical Trials
2,078 Total Patients Enrolled
Michael Bottlang, PhDPrincipal InvestigatorLegacy Clinical Research & Technology Center
1 Previous Clinical Trials
33 Total Patients Enrolled
~1 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top